FIELD: chemistry.
SUBSTANCE: present invention relates to a method for synthesis of 8-phenylmethoxy-5-((R)-2-halogen-1-hydroxyethyl)-(1H)-quinolin-2-ones or their acceptable solvates, involving reaction of 5-(α-halogenacetyl)-8-phenylmethoxy-(1H)-quinolin-2-one with a reducing agent in the presence of a chiral agent and a base to form 8-phenylmethoxy-5-((R)-2-halogen-1-hydroxyethyl)-(1H)-quinolin-2-one, where the said chiral agent is characterised by formula
or ,
where M represents Ru, Rh, Ir, Fe, Co or Ni, L represents C6-C24aryl or C6-C24aryl(C1-C10)aliphatic residue, in any case optionally bonded to a polymer, X represents hydrogen or halogen, R1 represents C1-C10aliphatic, C3-C10cycloaliphatic, C3-C10cycloaliphatic(C1-C10)aliphatic, C6-C24aryl or C6-C24aryl(C1-C10)aliphatic residue to a 4-12-member heterocyclic group which is optionally bonded to a polymer in each case, and R2 and R3 represent phenyl, or R2 and R3 together with the carbon atom to which they are bonded form cyclohexane or cycloheptane. The invention also relates to a method for synthesis of salts of 5-[(R)-2-(5,6-diethylindan-2-ylamino)-l-hydroxyethyl]-8-hydroxy-(1H)-quinolin-2-one, one of the steps of is synthesis of 8-phenylmethoxy-5-((R)-2-halogen-1-hydroxyethyl)-(1H)-quinolin-2-ones.
EFFECT: design of a new cheap and highly efficient enantioselective method for synthesis of quinoline derivatives.
10 cl, 1 tbl, 11 ex
Title |
Year |
Author |
Number |
METHOD OF OBTAINING 5-( α -HALOGEN ACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLINE-2-ONS |
2004 |
- Loze Oliv'E
- Penn Gerkhard
- Shilling Khanspeter
|
RU2339621C2 |
METHOD OF PRODUCTION OF 5-[(R)-2-(5,6-DIETHYLINDAN-2-YLAMINO)-1-HYDROXYETHYL]-8-HYDROXY-(1H)-QUINOLIN-2-ONE SALT WHICH IS USEFUL AS ADRENORECEPTOR AGONIST |
2004 |
|
RU2332405C2 |
COMPOUNDS, METHOD FOR PREPARING COMPOUND, PHARMACEUTICAL COMPOSITION |
2000 |
- Bernar Kenju
- Ajan Brjus
- Alek Robin Fehrkhehrst
- Dejvid Bitti
|
RU2244709C2 |
COMBINATIONS OF GLUCOPYRROLATE AND B-2 ADRENOCEPTOR ANTOGONISTS |
2005 |
|
RU2388465C2 |
QUINOLINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
2007 |
- Loze Oliv'E
- Monn'E Stefani
- Rebe Zhan-Lui
|
RU2449991C2 |
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS |
2010 |
- Kristin Brazerton-Plejss
- Ralf N'Ju Kharris Iii
- Brehdli Eh. Lo
- Fransisko-Khav'Er Lopes-Tapija
- Pankadzh D. Rege
- Dejvid Brjus Repke
- Rassel Stiven Stabler
- Kejt Adrian Marri Uolker
|
RU2533122C2 |
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA-2-ADRENERGIC RECEPTOR AGONIST ACTIVITY |
2013 |
- Rancati Fabio
- Linney Ian
- Knight Chris
- Schmidt Wolfgang
|
RU2661877C2 |
METHOD OF PRODUCTION OF MEVALONIC ACID DERIVATIVES INHIBITING HMG-COA REDUCTASE |
2003 |
- Zedel'Majer Gottfrid
- Mates Kristian
|
RU2335500C2 |
METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES |
2002 |
- Makichern Ehrnest Dzh.
- Bridzher Gari Dzh.
- Skupinska Kristina A.
- Skerldzh Renato T.
|
RU2308451C2 |
DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS |
2001 |
- Sui Zikhua
- Makajlehg Mark Dzh.
- Guan Dzhikhua
- Dzhiang Vejkvin
- Lehnter Dzhejms K.
|
RU2267490C2 |